Pandemic SARS CoV-2 has been present process speedy evolution throughout unfold all through the world ensuing within the emergence of many Spike protein variants, a few of which seem to both evade antibody neutralization, transmit extra effectively, or doubtlessly exhibit elevated virulence. This raises vital considerations relating to the long-term efficacy of safety elicited after major an infection and/or from vaccines derived from single virus Spike (S) genotypes, in addition to the efficacy of anti-S monoclonal antibody based mostly therapeutics.
Right here, we used totally human polyclonal human IgG (SAB-185), derived from hyperimmunization of transchromosomic bovines with DNA plasmids encoding the SARS-CoV-2 Wa-1 pressure S protein or purified ectodomain of S protein, to look at the neutralizing capability of SAB-185 in vitro and the protecting efficacy of passive SAB-185 antibody (Ab) switch in vivo . The Ab preparation was examined for neutralization towards 5 variant SARS-CoV-2 strains: Munich (Spike D614G), UK (B.1.1.7), Brazil (P.1) and SA (B.1.3.5) variants, and a variant remoted from a chronically contaminated immunocompromised affected person (Spike Δ144-146).
For the in vivo research, we used a brand new human ACE2 (hACE2) transgenic Syrian hamster mannequin that reveals lethality after SARS-Cov-2 problem and the Munich, UK, SA and Δ144-146 variants. SAB-185 neutralized every of the SARS-CoV-2 strains equivalently on Vero E6 cells, nonetheless, a management convalescent human serum pattern was much less efficient at neutralizing the SA variant. Within the hamster mannequin, prophylactic SAB-185 therapy protected the hamsters from deadly illness and minimized medical indicators of an infection.
These outcomes recommend that SAB-185 could also be an efficient therapy for sufferers contaminated with SARS CoV-2 variants. Earlier than vaccination, 59 people have been seronegative and the opposite 27 have been seropositive for SARS-CoV-2 antigens NP and/or RBD. Of the seronegative cohort, 42% didn’t develop a measurable IgG immune response towards RBD after the primary vaccine dose however all (100%) had a powerful IgG response after two vaccine doses. All seropositive people developed a powerful IgG antibody response towards RBD after the primary vaccine dose, with antibody ranges roughly 40% larger than the seronegative people who had obtained two doses. Furthermore, the beforehand seropositive topics confirmed no vital enhance in IgG antibody response towards RBD after the second vaccine dose.
Important Associations of IgG Glycan Buildings With Continual Graft-Versus-Host Illness Manifestations: Outcomes of the Cross-Sectional NIH Cohort Examine
Continual graft-versus-host illness (cGvHD) is a systemic alloimmune and autoimmune dysfunction and a significant late complication of allogeneic hematopoietic stem cell transplantation (alloHSCT). The illness is characterised by an altered homeostasis of the humoral immune response. Immunoglobulin G (IgG) glycoprotein is the principle effector molecule of the humoral immune response. Modifications in IgG glycosylation are related to plenty of autoimmune illnesses. IgG glycosylation evaluation was performed by the technique of liquid chromatography within the Nationwide Institutes of Well being (NIH) cohort of 213 cGvHD sufferers.

The outcomes confirmed statistically vital variations with reference to cGvHD NIH joint/fascia and pores and skin rating, illness exercise and depth of systemic immunosuppression. ROC evaluation confirmed that IgG glycosylation will increase specificity and sensitivity of fashions utilizing laboratory parameters and markers of irritation related to cGvHD (eosinophil depend, complement parts C3 and C4 and irritation markers: albumin, CRP and thrombocyte depend). This analysis exhibits that IgG glycosylation might play a major function in cGvHD pathology. Additional analysis might contribute to the understanding of the illness biology and result in the medical biomarker growth to permit customized approaches to continual GvHD remedy.
A lightweight-initiated chemiluminescent assay for the detection of youngsters’s milk protein-specific IgE with glorious capability to keep away from interference of particular IgG
The detection of allergen-specific IgE is of worth for the prognosis of youngsters’s milk allergy. Nonetheless, its accuracy will intervene with the presence of excessive ranges of particular IgG within the serum of youngsters with milk allergy. To unravel this drawback, we established a light-initiated chemiluminescent assay (LICA) based mostly on nanomicrospheres, which neutralized the interference of particular IgG by rising the quantity of antigen coated on the microspheres. The power of this methodology to withstand IgG interference was confirmed by including additional particular IgG to the serum of allergic sufferers. Lastly, the optimistic fee of allergen-specific IgE was elevated to 85%, which was higher than the oblique ELISA (70%), indicating that this methodology has sure benefits for the detection of particular IgE in kids with milk allergy.
Anti-SARS-CoV-2 antibodies have been used within the research of the immune response in contaminated sufferers. Nonetheless, variations in sensitivity and specificity have been reported, relying on the strategy of study. The goal of the current research was to guage the diagnostic accuracy of an algorithm through which a high-throughput automated assay for complete antibodies was used for screening and two semi-automated IgG-specific strategies have been used to substantiate the outcomes, and likewise to correlate the analytical outcomes with the medical knowledge and the time elapsed since an infection.
Goat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-g-96T |
DL Develop |
96T |
EUR 721.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Goat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Hu-48T |
DL Develop |
48T |
EUR 286.8 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Human Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Hu-96T |
DL Develop |
96T |
EUR 350.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human Immunoglobulin G (IgG) in samples from serum, plasma or other biological fluids. |
Mouse Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Mu-48T |
DL Develop |
48T |
EUR 393.6 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Mu-96T |
DL Develop |
96T |
EUR 498 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Porcine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-p-48T |
DL Develop |
48T |
EUR 547.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Porcine Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-p-96T |
DL Develop |
96T |
EUR 708 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Ra-48T |
DL Develop |
48T |
EUR 400.8 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Ra-96T |
DL Develop |
96T |
EUR 506.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Rb-48T |
DL Develop |
48T |
EUR 404.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Rb-96T |
DL Develop |
96T |
EUR 511.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 543.6 |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 750 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 543.6 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 750 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 376.8 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RD-IgG-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 513.6 |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 567.6 |
Bovine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 784.8 |
Canine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 546 |
Canine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 754.8 |
Equine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Eq-48Tests |
Reddot Biotech |
48 Tests |
EUR 429.6 |
Equine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Eq-96Tests |
Reddot Biotech |
96 Tests |
EUR 588 |
Goat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-g-48Tests |
Reddot Biotech |
48 Tests |
EUR 578.4 |
Goat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-g-96Tests |
Reddot Biotech |
96 Tests |
EUR 800.4 |
Human Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 259.2 |
Human Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 344.4 |
Mouse Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 385.2 |
Mouse Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 525.6 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-p-48Tests |
Reddot Biotech |
48 Tests |
EUR 567.6 |
Porcine Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-p-96Tests |
Reddot Biotech |
96 Tests |
EUR 784.8 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 393.6 |
Rat Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 536.4 |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Rb-48Tests |
Reddot Biotech |
48 Tests |
EUR 397.2 |
Rabbit Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Rb-96Tests |
Reddot Biotech |
96 Tests |
EUR 541.2 |
Guinea pig Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Gu-48T |
DL Develop |
48T |
EUR 378 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Guinea pig Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Guinea pig Immunoglobulin G (IgG) ELISA Kit |
DLR-IgG-Gu-96T |
DL Develop |
96T |
EUR 475.2 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Guinea pig Immunoglobulin G (IgG) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Guinea pig Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Gu-48Tests |
Reddot Biotech |
48 Tests |
EUR 366 |
Guinea pig Immunoglobulin G (IgG) ELISA Kit |
RDR-IgG-Gu-96Tests |
Reddot Biotech |
96 Tests |
EUR 498 |
IgG Antibody |
1-CSB-PA00760E0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is Unconjugated. Tested in the following application: ELISA |
IgG Antibody |
1-CSB-PA00770E0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
IgG Antibody |
1-CSB-PA00780E0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
IgG Antibody |
1-CSB-PA00790E0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
IgG antibody |
10-2705 |
Fitzgerald |
1 mg |
EUR 159.6 |
Description: Mouse Monoclonal IgG antibody |
Human IgG antibody |
10R-8446 |
Fitzgerald |
100 ul |
EUR 471.6 |
Description: Mouse monoclonal Human IgG antibody |
Human IgG antibody |
10-3150 |
Fitzgerald |
1 mg |
EUR 249.6 |
Description: Mouse Monoclonal Human IgG antibody |
IgG-Fc Antibody |
20-abx137072 |
Abbexa |
|
|
|
IgG (Fab) Antibody |
abx140204-01mg |
Abbexa |
0.1 mg |
EUR 376.8 |
|
IgG (Fc) Antibody |
abx140270-01mg |
Abbexa |
0.1 mg |
EUR 376.8 |
|
IgG (Fc) Antibody |
abx140321-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
Human IgG Antibody |
abx019200-5mg |
Abbexa |
5 mg |
EUR 276 |
|
Mouse IgG Antibody |
abx019214-5mg |
Abbexa |
5 mg |
EUR 309.6 |
|
Human IgG Antibody |
abx234077-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
IgG control Antibody |
abx234182-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Anti-IgG antibody |
STJ400110 |
St John's Laboratory |
1 mg |
EUR 459.6 |
Description: Immunoglobulin G (IgG) is a monomeric immunoglobulin, built of two heavy chains and two light chains. Each IgG has two antigen binding sites. It is the most abundant immunoglobulin and is approximately equally distributed in blood and in tissue liquids, constituting 75 % of serum immunoglobulins in humans. There are four IgG subclasses (IgG1, 2, 3 and 4) in humans, named in order of their abundance in serum (IgG1 being the most abundant). |
Anti-IgG antibody |
STJ400111 |
St John's Laboratory |
1 mg |
EUR 459.6 |
Description: Immunoglobulin G (IgG) is a monomeric immunoglobulin, built of two heavy chains and two light chains. Each IgG has two antigen binding sites. It is the most abundant immunoglobulin and is approximately equally distributed in blood and in tissue liquids, constituting 75 % of serum immunoglobulins in humans. There are four IgG subclasses (IgG1, 2, 3 and 4) in humans, named in order of their abundance in serum (IgG1 being the most abundant). |
Human Adenovirus Antibody IgG (ADV IgG) ELISA Kit |
abx052155-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx354313-96tests |
Abbexa |
96 tests |
EUR 943.2 |
|
Mouse Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx354531-96tests |
Abbexa |
96 tests |
EUR 943.2 |
|
Chicken Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx355873-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Pig Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx361882-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rabbit Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx362353-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Sheep Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx364584-96tests |
Abbexa |
96 tests |
EUR 1111.2 |
|
Monkey Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx359940-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx253447-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
Mouse Anticardiolipin Antibody IgG (aCL IgG) ELISA Kit |
abx254641-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
IgG Immunoglobulin(IG217) Antibody |
BNCA0217-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against IgG Immunoglobulin(IG217), APC conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCA0266-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against IgG Immunoglobulin(IG266), APC conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCAP0217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCAP0217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCAP0266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCAP0266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
IgG Antibody, HRP conjugated |
1-CSB-PA00760F0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is HRP conjugated. Tested in the following application: ELISA |
IgG Antibody, FITC conjugated |
1-CSB-PA00760G0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is FITC conjugated. Tested in the following application: ELISA |
IgG Antibody, Biotin conjugated |
1-CSB-PA00760H0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is Biotin conjugated. Tested in the following application: ELISA |
IgG Antibody, HRP conjugated |
1-CSB-PA00770F0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is HRP conjugated. Tested in the following application: ELISA |
IgG Antibody, FITC conjugated |
1-CSB-PA00770G0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is FITC conjugated. Tested in the following application: ELISA |
IgG Antibody, Biotin conjugated |
1-CSB-PA00770H0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Goat. This antibody is Biotin conjugated. Tested in the following application: ELISA |
IgG Antibody, HRP conjugated |
1-CSB-PA00780F0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
IgG Antibody, FITC conjugated |
1-CSB-PA00780G0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
IgG Antibody, Biotin conjugated |
1-CSB-PA00780H0Gp |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
IgG Antibody, HRP conjugated |
1-CSB-PA00790F0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
IgG Antibody, FITC conjugated |
1-CSB-PA00790G0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
IgG Antibody, Biotin conjugated |
1-CSB-PA00790H0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against IgG. Recognizes IgG from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
IgG Immunoglobulin(IG217) Antibody |
BNC610217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF660R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC610217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF660R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC610266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF660R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC610266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF660R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC680217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF568 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC680217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF568 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC680266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF568 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC680266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF568 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCR0217-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against IgG Immunoglobulin(IG217), RPE conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCR0266-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against IgG Immunoglobulin(IG266), RPE conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNUB0217-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Concentration: 0.2mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNUB0217-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Concentration: 0.2mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNUB0266-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Concentration: 0.2mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNUB0266-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Concentration: 0.2mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC430217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF543 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC430217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF543 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC430266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF543 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC430266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF543 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC470217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF647 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC470217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF647 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC470266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF647 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC470266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF647 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC400217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF640R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC400217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF640R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC400266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF640R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC400266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF640R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC880217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF488A conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC880217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF488A conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC880266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF488A conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC880266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF488A conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC810217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF680R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC810217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF680R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC810266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF680R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC810266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF680R conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCP0217-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against IgG Immunoglobulin(IG217), PerCP conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCP0266-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against IgG Immunoglobulin(IG266), PerCP conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNUM0217-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against IgG Immunoglobulin(IG217), 1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNUM0266-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against IgG Immunoglobulin(IG266), 1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC050217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF405M conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC050217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF405M conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC050266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF405M conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC050266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF405M conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC700217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF770 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC700217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF770 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC700266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF770 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC700266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF770 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC800217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF680 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC800217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF680 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC800266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF680 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC800266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF680 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCB0217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Biotin conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCB0217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Biotin conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCB0266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Biotin conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCB0266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Biotin conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC940217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF594 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC940217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF594 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC940266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF594 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC940266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF594 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC550217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF555 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC550217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF555 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC550266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF555 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC550266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF555 conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCH0217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNCH0217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCH0266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNCH0266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
anti- Human IgG antibody |
FNab04077 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against Human IgG |
anti- IgG control antibody |
FNab04182 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against IgG control |
FITC antibody (IgG fraction) |
20C-CR1056SP |
Fitzgerald |
1 ml |
EUR 289.2 |
Description: Rabbit polyclonal FITC antibody |
IgG Isotype Control antibody |
10R-6524 |
Fitzgerald |
50 ug |
EUR 159.6 |
Description: Armenian Hamster monoclonal IgG Isotype Control antibody |
IgG Isotype Control antibody |
10R-6525 |
Fitzgerald |
50 ug |
EUR 159.6 |
Description: Syrian Hamster monoclonal IgG Isotype Control antibody |
IgG kappa chain antibody |
10-1935 |
Fitzgerald |
200 ul |
EUR 651.6 |
Description: Mouse monoclonal IgG kappa chain antibody |
Immunoglobulin G (IgG) Antibody |
20-abx101285 |
Abbexa |
-
EUR 343.20
-
EUR 134.40
-
EUR 844.80
-
EUR 427.20
-
EUR 292.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101286 |
Abbexa |
-
EUR 292.80
-
EUR 134.40
-
EUR 610.80
-
EUR 343.20
-
EUR 260.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101287 |
Abbexa |
-
EUR 343.20
-
EUR 134.40
-
EUR 828.00
-
EUR 427.20
-
EUR 292.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101288 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101289 |
Abbexa |
-
EUR 360.00
-
EUR 844.80
-
EUR 427.20
-
EUR 184.80
-
EUR 292.80
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101290 |
Abbexa |
-
EUR 427.20
-
EUR 134.40
-
EUR 1245.60
-
EUR 627.60
-
EUR 360.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101291 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101292 |
Abbexa |
-
EUR 526.80
-
EUR 142.80
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101293 |
Abbexa |
-
EUR 560.40
-
EUR 159.60
-
EUR 1646.40
-
EUR 777.60
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101294 |
Abbexa |
-
EUR 427.20
-
EUR 1144.80
-
EUR 577.20
-
EUR 184.80
-
EUR 326.40
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx101295 |
Abbexa |
-
EUR 427.20
-
EUR 159.60
-
EUR 1195.20
-
EUR 594.00
-
EUR 360.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx104924 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx104928 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
IgG (H+L) Antibody |
20-abx159552 |
Abbexa |
|
|
|
Immunoglobulin G (IgG) Antibody |
20-abx172872 |
Abbexa |
|
|
|
Immunoglobulin G (IgG) Antibody |
20-abx172873 |
Abbexa |
|
|
|
Immunoglobulin G (IgG) Antibody |
20-abx172874 |
Abbexa |
-
EUR 410.40
-
EUR 1045.20
-
EUR 543.60
-
EUR 184.80
-
EUR 326.40
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx172875 |
Abbexa |
|
|
|
Immunoglobulin G (IgG) Antibody |
20-abx132116 |
Abbexa |
-
EUR 393.60
-
EUR 1011.60
-
EUR 526.80
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx132131 |
Abbexa |
-
EUR 393.60
-
EUR 1011.60
-
EUR 526.80
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx132132 |
Abbexa |
-
EUR 427.20
-
EUR 1095.60
-
EUR 560.40
-
EUR 184.80
-
EUR 326.40
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx132398 |
Abbexa |
-
EUR 326.40
-
EUR 678.00
-
EUR 376.80
-
EUR 184.80
-
EUR 276.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
IgG light chain Antibody |
abx140241-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
IgG (Fab) Antibody (PE) |
abx140309-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
IgG (Fc) Antibody (FITC) |
abx140320-01mg |
Abbexa |
0.1 mg |
EUR 460.8 |
|
Immunoglobulin G (IgG) Antibody |
20-abx130163 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx130476 |
Abbexa |
-
EUR 560.40
-
EUR 151.20
-
EUR 1646.40
-
EUR 777.60
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
20-abx130516 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1579.20
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Immunoglobulin G (IgG) Antibody |
abx018252-100ug |
Abbexa |
100 ug |
EUR 460.8 |
|
Immunoglobulin G (IgG) Antibody |
abx018253-100ug |
Abbexa |
100 ug |
EUR 460.8 |
|
Immunoglobulin G (IgG) Antibody |
abx018254-100ug |
Abbexa |
100 ug |
EUR 460.8 |
|
Human IgG Antibody (HRP) |
abx019201-01ml |
Abbexa |
0.1 ml |
EUR 276 |
|
IgG Immunoglobulin(IG217) Antibody |
BNC040217-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF405S conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG217) Antibody |
BNC040217-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG217), CF405S conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC040266-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF405S conjugate, Concentration: 0.1mg/mL |
IgG Immunoglobulin(IG266) Antibody |
BNC040266-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against IgG Immunoglobulin(IG266), CF405S conjugate, Concentration: 0.1mg/mL |
The algorithm and automatic assay alone had a specificity and a optimistic predictive worth of 100%, though the sensitivity and unfavorable predictive worth of the algorithm was larger. Each strategies confirmed sensitivity from day 11 of the onset of signs in asymptomatic and symptomatic sufferers. The absorbance of the overall antibodies was considerably larger in severely symptomatic than in asymptomatic or mildly symptomatic sufferers, which suggests the antibody stage was larger. We discovered 15 sufferers that didn’t current seroconversion at 12 days from the onset of signs or the primary polymerase chain response take a look at.